The aim of the European Virus Archive project is to create and mobilise a European network of high calibre centres with the appropriate expertise, to collect, amplify, characterise, standardise, authenticate, distribute and track, mammalian and other exotic viruses. The EVA project is establishing a web-based catalogue to advertise and distribute viruses in the collection as well as associated products. In addition the EVA network also produce associated reagents on demand, to laboratories throughout Europe and also worldwide.

Site Map | contact |

EVA: European Virus Archive

EVA: European Virus Archive

EVA: European Virus Archive

Objectives of the project

The management structure of EVA will ensure the highest standards of quality assurance, security, traceability and dissemination for the benefit of science, medicine, education and global information.


5. EVA as a structure interacting with other fields of research to increase scientific knowledge and to drive industrial development

EVA has the potential to generate a new open attitude to offset the often observed “closed door philosophy†of scientists from different disciplines. The successful creation and subsequent maturation of EVA with an integrated extranet that can out-source the collection, and expertise of the partners, will generate closer interactions between scientists from many related disciplines. EVA will directly encourage these interactions by planning workshops, international conferences, educational and informational videos, and exploitation of the intranet information capabilities. Where possible, EVA will directly facilitate cross-disciplinary collaboration and a more open approach to the sharing of knowledge and technologies. EVA will look for opportunities to encourage direct interactions between academia and industry to the mutual benefit of both areas of science. Special attention will be given to facilitate interactions with the industrial community. Using a dedicated website interface, the EVA users platform, will promote EVA foreground to the Industry. The derived products activities (JR8 workpackage) will contribute to the establishment of robust relationships with industrial groups in providing unique resources (antigens, viral proteins, viral enzymes) necessary, for instance, for antiviral drug development or for the production of diagnostic kits.